{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:47:43Z","timestamp":1790426863102,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010112","name":"Southern Medical University Nanfang Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["21625210"],"award-info":[{"award-number":["21625210"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.tranon.2026.102803","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T20:15:02Z","timestamp":1778184902000},"page":"102803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["CPT1B promotes acute myeloid leukemia progression via fatty acid oxidation\u2013dependent metabolic reprogramming"],"prefix":"10.1016","volume":"69","author":[{"given":"Rui","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Ling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-E","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2026.102803_bib0001","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1080\/10428194.2020.1713320","article-title":"Very late acute myeloid leukemia relapse: clinical features, treatment and outcome","volume":"62","author":"Mariani","year":"2021","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.tranon.2026.102803_bib0002","article-title":"Drug-tolerant persister cells in acute myeloid leukemia: pressing challenge and promising new strategies for treatment","volume":"12","author":"Li","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.tranon.2026.102803_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.949261","article-title":"Comparative analysis of extracellular vesicle isolation methods from human AML bone marrow cells and AML cell lines","volume":"12","author":"Lang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2026.102803_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114966","article-title":"Curcumin combined with arsenic trioxide enhances autophagy and immune surveillance to inhibit immune escape in acute myeloid leukemia","volume":"159","author":"Zhang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.tranon.2026.102803_bib0005","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41392-020-00361-x","article-title":"Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy","volume":"5","author":"Carter","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tranon.2026.102803_bib0006","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3892\/mmr.2022.12871","article-title":"Abnormal expression of HADH, an enzyme of fatty acid oxidation, affects tumor development and prognosis (review)","volume":"26","author":"Wang","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.tranon.2026.102803_bib0007","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s10495-015-1137-x","article-title":"Carnitine transporter CT2 (SLC22A16) is over-expressed in acute myeloid leukemia (AML) and target knockdown reduces growth and viability of AML cells","volume":"20","author":"Wu","year":"2015","journal-title":"Apoptosis"},{"key":"10.1016\/j.tranon.2026.102803_bib0008","first-page":"2477","article-title":"The role and therapeutic implication of CPTs in fatty acid oxidation and cancers progression","volume":"11","author":"Wang","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.tranon.2026.102803_bib0009","article-title":"Identification of CPT1A as a prognostic biomarker and potential therapeutic target for kidney renal clear cell carcinoma and establishment of a risk signature of CPT1A-related genes","volume":"2020","author":"Xu","year":"2020","journal-title":"Int. J. Genom."},{"key":"10.1016\/j.tranon.2026.102803_bib0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ebiom.2016.11.025","article-title":"High expression of CPT1A predicts adverse outcomes: a potential therapeutic target for acute myeloid leukemia","volume":"14","author":"Shi","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tranon.2026.102803_bib0011","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1113\/JP284248","article-title":"CPT1C is required for synaptic plasticity and oscillatory activity that supports motor, associative and non-associative learning","volume":"601","author":"Iborra-L\u00e1zaro","year":"2023","journal-title":"J. Physiol."},{"key":"10.1016\/j.tranon.2026.102803_bib0012","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4172\/2155-6156.1000401","article-title":"Carnitine palmitoyltransferase 1b deficiency protects mice from diet-induced insulin resistance","volume":"5","author":"Kim","year":"2014","journal-title":"J. Diabetes Metab."},{"key":"10.1016\/j.tranon.2026.102803_bib0013","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.7150\/ijbs.69802","article-title":"Acyl-CoA synthetase long-chain 3-mediated fatty acid oxidation is required for TGF\u03b21-induced epithelial-mesenchymal transition and metastasis of colorectal carcinoma","volume":"18","author":"Quan","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.tranon.2026.102803_bib0014","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000043295","article-title":"Causal association of metabolic biomarkers and the risk of esophageal cancer: a 2-sample Mendelian randomization study","volume":"104","author":"Ziyang","year":"2025","journal-title":"Medicine"},{"key":"10.1016\/j.tranon.2026.102803_bib0015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fonc.2020.00155","article-title":"Fatty acid metabolism, bone marrow adipocytes, and AML","volume":"10","author":"Tabe","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2026.102803_bib0016","doi-asserted-by":"crossref","first-page":"138","DOI":"10.20517\/cdr.2022.133","article-title":"Resistance to energy metabolism - targeted therapy of AML cells residual in the bone marrow microenvironment","volume":"6","author":"Tabe","year":"2023","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.tranon.2026.102803_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/biology13110892","article-title":"The role of the CPT family in cancer: searching for new therapeutic strategies","volume":"13","author":"Duan","year":"2024","journal-title":"Biology"},{"key":"10.1016\/j.tranon.2026.102803_bib0018","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12967-021-02848-9","article-title":"Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199","volume":"19","author":"Mao","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.tranon.2026.102803_bib0019","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3233\/CBM-210043","article-title":"CPT1B, a metabolic molecule, is also an independent risk factor in CN-AML","volume":"37","author":"Ling","year":"2023","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.tranon.2026.102803_bib0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.semcancer.2022.07.005","article-title":"Cancer depends on fatty acids for ATP production: a possible link between cancer and obesity","volume":"86","author":"Lee","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.tranon.2026.102803_bib0021","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ijc.35380","article-title":"Targeting fatty acid oxidation: a potential strategy for treating gastrointestinal tumors","volume":"157","author":"Zheng","year":"2025","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tranon.2026.102803_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111044","article-title":"Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipids","volume":"39","author":"Li","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.tranon.2026.102803_bib0023","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1038\/s41375-025-02645-z","article-title":"Targeting lipid metabolism in acute myeloid leukemia: biological insights and therapeutic opportunities","volume":"39","author":"Dembitz","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.tranon.2026.102803_bib0024","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.70000","article-title":"Reprogramming of fatty acid metabolism in acute leukemia","volume":"240","author":"Sokei","year":"2025","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.tranon.2026.102803_bib0025","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.cmet.2018.04.018","article-title":"JAK\/STAT3-regulated fatty acid \u03b2-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance","volume":"27","author":"Wang","year":"2018","journal-title":"Cell Metab."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326001403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326001403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:26:28Z","timestamp":1783178788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326001403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":25,"alternative-id":["S1936523326001403"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102803","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CPT1B promotes acute myeloid leukemia progression via fatty acid oxidation\u2013dependent metabolic reprogramming","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102803","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102803"}}